Linked Life Data

19043153

Source:http://linkedlifedata.com/resource/pubmed/id/19043153

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-12-1
pubmed:databankReference
pubmed:abstractText
Despite the prevalence and clinical significance of borderline personality disorder, its treatment remains understudied.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1472-1465
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
193
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
485-92
pubmed:dateRevised
2009-9-30
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study.
pubmed:affiliation
Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN 55454, USA. scs@umn.edu
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study